ADTX Aditxt Inc.

USD 1.61 0.00 0
Icon

Aditxt Inc. (ADTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.61

0.00 (0.00)%

USD 3.21M

0.02M

N/A

USD 2.00 (+24.22%)

Icon

ADTX

Aditxt Inc. (USD)
COMMON STOCK | NSD
USD 1.61
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.21M

USD 2.00 (+24.22%)

USD 1.61

Aditxt Inc. (ADTX) Stock Forecast

N/A

Based on the Aditxt Inc. stock forecast from 0 analysts, the average analyst target price for Aditxt Inc. is not available over the next 12 months. Aditxt Inc. ’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aditxt Inc. is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Aditxt Inc. ’s stock price was USD 1.61. Aditxt Inc. ’s stock price has changed by +10.27% over the past week, -0.62% over the past month and -90.53% over the last year.

No recent analyst target price found for Aditxt Inc.
No recent average analyst rating found for Aditxt Inc.

Company Overview Aditxt Inc.

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor t...Read More

https://www.aditxt.com

737 North Fifth Street, Richmond, VA, United States, 23219

47

December

USD

USA

Adjusted Closing Price for Aditxt Inc. (ADTX)

Loading...

Unadjusted Closing Price for Aditxt Inc. (ADTX)

Loading...

Share Trading Volume for Aditxt Inc. Shares

Loading...

Compare Performance of Aditxt Inc. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ADTX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aditxt Inc. (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing ADTX

Symbol Name ADTX's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Aditxt Inc. (ADTX) Stock

Stock Target Advisor's fundamental analysis for Aditxt Inc. 's stock is Bearish.

Unfortunately we do not have enough data on ADTX's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ADTX's stock to indicate what its average analyst target is.

ADTX stock's Price/Earning ratio is -99,999.99. Our analysis grades ADTX stock's Price / Earning ratio at A+. This means that ADTX stock's Price/Earning ratio is above 3.000000000000003% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ADTX may be undervalued for its sector.

The last closing price of ADTX's stock was USD 1.61.

The most recent market capitalization for ADTX is USD 3.21M.

Unfortunately we do not have enough analyst data on ADTX's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Aditxt Inc. 's stock.

As per our most recent records Aditxt Inc. has 47 Employees.

Aditxt Inc. 's registered address is 737 North Fifth Street, Richmond, VA, United States, 23219. You can get more information about it from Aditxt Inc. 's website at https://www.aditxt.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...